Enzo Biochem, Inc. Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment

Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment - USD ($) $ in Thousands	Jul. 31, 2022	Jul. 31, 2021
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 11,516	$ 10,198
Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 6,754	$ 6,016
Accounts receivable net, current, percentage	100.00%	100.00%
Life science [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 4,762	$ 4,182
Third party payers [Member] \| Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 2,647	$ 2,195
Accounts receivable net, current, percentage	40.00%	36.00%
Patient self-pays [Member] \| Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 2,779	$ 2,007
Accounts receivable net, current, percentage	41.00%	33.00%
Medicare [Member] \| Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 768	$ 1,122
Accounts receivable net, current, percentage	11.00%	19.00%
Health maintenance organizations [Member] \| Clinical Labs [Member]
Summary of Significant Accounting Policies (Details) - Schedule of net accounts receivable by segment [Line Items]
Accounts receivable net, current	$ 560	$ 692
Accounts receivable net, current, percentage	8.00%	12.00%